Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas

Journal of Clinical Neuroscience

Volumn 19, Issue 11, 2012, Pages 1535-1540

  Marko, Nicholas F ^a,b   Coughlan, Carolyn ^d   Weil, Robert J ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NEUROLOGICAL INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression profiling; Gross total resection; Microarray; Neuro oncology; Neuroendocrinology; Neurosurgical oncology; Surgical resection

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CHL1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MINIMAL RESIDUAL DISEASE; NEUROIMAGING; NONFUNCTIONING PITUITARY ADENOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; TRANSCRIPTOMICS; TUMOR RECURRENCE;

AGED; CELL ADHESION MOLECULES; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; SAMPLE SIZE;

EID: 84867101129     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.01.038     Document Type: Article

References (37)

1. J. Gsponer, N. De Tribolet, and J.P. Déruaz Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses: retrospective analysis of 353 patients Medicine (Baltimore) 78 1999 236 269
2. S. Ezzat, S.L. Asa, and W.T. Couldwell The prevalence of pituitary adenomas: a systematic review Cancer 101 2004 613 619
3. J.A. Wass, and N. Karavitaki Nonfunctioning pituitary adenomas: the Oxford experience Nat Rev Endocrinol 5 2009 519 522
4. M. Losa, P. Mortini, and R. Barzaghi Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence J Neurosurg 108 2008 525 532
5. S. Dubois, S. Guyétant, and P. Menei Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery Eur J Endocrinol 157 2007 141 147
6. O.M. Dekkers, A.M. Pereira, and J.A. Romijn Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas J Clin Endocrinol Metab 93 2008 3717 3726
7. Y. Greenman, and N. Stern How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery? Clin Endocrinol 70 2009 829 832
8. P.U. Freda, A.M. Beckers, and L. Katznelson Pituitary incidentaloma: an endocrine society clinical practice guideline J Clin Endocrinol Metab 96 2011 894 904
9. D.C. Brown, and K.C. Gatter Monoclonal antibody Ki-67: its use in histopathology Histopathology 17 1990 489 503
10. R. Gejman, B. Swearingen, and E.T. Hedley-Whyte Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas Hum Pathol 39 2008 758 766
11. J. Gerdes, V. Schwab, and H. Lemke Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation Int J Cancer 31 1983 13 20
12. J. Gerdes, H. Lemke, and H. Baisch Cell type analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1984 1710 1715
13. P.M. Doyle, W.A. Thiryayi, and A. Joshi Beta human chorionic gonadotropin (b-hCG) expression in pituitary adenomas: relationship to endocrine function and tumour recurrence Pituitary 12 2009 190 195
14. S.M. Ekramullah, Y. Saitoh, and N. Arita The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas Acta Neurochir 138 1996 1449 1455
15. M. Filippella, F. Galland, and M. Kujas Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study Clin Endocrinol 65 2006 536 543
16. G. Kontogeorgos Predictive markers of pituitary adenoma behavior Neuroendocrinology 83 2006 179 188
17. T. Mizoue, H. Kawamoto, and K. Arita MIB-1 immunopositivity is associated with rapid regrowth of pituitary adenomas Acta Neurochir 139 1997 426 432
18. T.W. Noh, H.J. Jeong, and M.K. Lee Predicting recurrence of nonfunctioning pituitary adenomas J Clin Endocrinol Metab 94 2009 4406 4413
19. C.B. Pizarro, M.C. Olivieira, and L.B. Coutinho Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody Braz J Med Biol Res 37 2004 235 243
20. M. Shibuya, F. Saito, and T. Miwa Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxy-uridine labeling, and nucleolar organizer region counts Acta Neuropathol 84 1992 178 183
21. Y. Tanaka, K. Hongo, and T. Tada Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlation among tumor volume doubling time, patient age, and MIB-1 index J Neurosurg 98 2003 359 365
22. G. Widhalm, S. Wolfsberger, and M. Preusser Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression J Neurosurg 111 2009 563 571
23. T. Zornitzki, H. Knobler, and D. Nass Increased MIB-1/Ki-67 index as a predictor of an aggressive course in a case of prolactinoma Horm Res 61 2004 111 116
24. A.J. Espay, B. Azzarelli, and L. Williams Recurrence in pituitary adenomas in childhood and adolescence J Child Neurol 16 2001 364 367
25. M. Losa, A. Franzin, and F. Mangili Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results Neurosurgery 47 2000 1313 1319
26. M. Pawlikowski, and K. Winczyk Immunohistochemical detection of prothymosin alpha in pituitary adenomas - a new marker of tumor recurrence? Folia Histochem Cytobiol 47 2009 559 562
27. S. Schreiber, W. Saeger, and D.K. Lüdecke Proliferation markers in different types of clinically non-secreting pituitary adenomas Pituitary 1 1999 213 220
28. K. Yonezawa, N. Tamaki, and T. Kokunai Clinical features and growth fractions of pituitary adenoma Surg Neurol 48 1997 494 500
29. D.W. Hsu, F. Hakim, and B.M.K. Biller Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence J Neurosurg 78 1993 753 761
30. R.J. Bohinski, R.E. Warnick, and M.F. Gaskill-Shipley Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery Neurosurgery 49 2001 1133 1144
31. A.I. Saeed, V. Sharov, and J. White TM4: a free, open-source system for microarray data management and analysis Biotechniques 34 2003 374 378
32. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 2001 5116 5121
33. M.B. Eisen, P.T. Spellman, and P.O. Brown Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 1998 14863 14868
34. S. Raychaudhuri, J.M. Stuart, and R.B. Altman Principal components analysis to summarize microarray experiments: application to sporulation time series Pac Symp Biocomput 2000 455 466
35. S. Chen, N. Mantei, and L. Dong Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1 J Neurobiol 38 1999 428 439
36. N.F. Marko, S.A. Toms, and G.H. Barnett Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study Genomics 91 2008 395 406
37. N.F. Marko, R.A. Prayson, and G.H. Barnett Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study Genomics 95 2010 16 24